The independent source for health policy research, polling, and news.
8,881-8,900 of 113,016 results
Senators are backing the Federal PFAS Research Evaluation Act with the goal of driving research into the health impacts of PFAS contamination. And actor Mark Ruffalo joins advocates raising awareness of the issue. Separately, lawmakers are scrutinizing the patents around cancer drug Keytruda.
Vice President Kamala Harris is meeting with reproductive rights groups at the White House Friday and speak in defense of the drug used in medicated abortions, as well as the "authority" of the FDA, a U.S. official told Reuters. News outlets look ahead to a critical decision expected soon from a Texas judge.
In a survey, 37% of Republican respondents view the fentanyl-opioid crisis as the biggest U.S. public health threat. 17% of Democrats ranked the epidemic as their top concern. In other news, Kansas moves closer to joining other states that are legalizing fentanyl test strips.
With generative AI in the news, Google and Microsoft officials spoke on the use of AI in health care, highlighting problems from implicit racial biases built into health data. Meanwhile, CIDRAP reports that celebrity Twitter users helped swing public opinion on pandemic responses.
Today's early morning highlights from the major news organizations.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Editorial writers delve into these public health topics.
Environmental Protection Agency Administrator Michael Regan says the agency will not "second-guess" symptoms reported after the toxic train derailment incident. Newsweek explains local residents may get Medicare for life. Meanwhile, Florida's surgeon general is investigated.
A Pew Research poll reported on by the Hill shows a majority of Americans wouldn't be comfortable with health providers relying on artificial intelligence as part of care — only 39% would be comfortable. Meanwhile, the CDC has recommended that Bavarian Nordic's mpox shots be given to all adults who are at risk.
A new study shows exposure to forever chemicals can disrupt metabolism of fats and amino acids in children and young adults, potentially leading to risks for a variety of illnesses. Separate research shows pancreatic cancer rates are rising faster for women than for men.
A new Axios-Ipsos American Health Index study shows that health care costs worry Americans the most. In Florida, a young boy's death from Strep A is driving concerns about the infection. Separately, the CDC says the flu shot provided relatively good protection this season.
Reuters reports that a request from the Alzheimer's Association to reduce coverage limits on Alzheimer's treatments has been turned down by the Centers for Medicare and Medicaid Services. Separately, the debt ceiling fight is being used to "fend off" changes to private Medicare Advantage plans.
Organizations like the Center for Reproductive Rights and the ACLU are teaming up to provide legal support to patients and abortion providers as laws shift in the states. Other abortion stories are reported from New Mexico, Kentucky, North Carolina, and elsewhere.
AP reports Indiana lawmakers advanced a bill that would ban "all gender-affirming care" in the state, in a move opponents say targets trans people. CBS News says a bill in Texas would also ban nearly all gender care. And in Indiana, lawmakers moved to block state funding for the Kinsey Institute.
Efforts to reduce maternal deaths have plateaued or declined in many parts of the world, reversing previous progress according to data from United Nations agencies. 287,000 maternal deaths were reported in 2020.
Today's early morning highlights from the major news organizations.
Read recent commentaries about drug-cost issues.
CDC epidemiologists and environmental health scientists are in Ohio, Politico says. Meanwhile, the EPA has ordered the train operator, Norfolk Southern, to pay all cleanup costs. Other health news is from Utah, Florida, New York, Georgia, Connecticut, North Carolina, and elsewhere.
Pfizer said Tuesday that the Food and Drug Administration is expected to make a decision on its respiratory syncytial virus vaccine in August. Separately, Teva has secured FDA approval for a modified formulation of its nervous system disorders drug Asustedo.
Editorial writers examine these public health topics.
© 2026 KFF